Browse
Bitter pill or market opportunity – how will EU pharma adapt to RFK Jr’s health reforms?
Fredrik Erixon comments in Euractiv on EU sector for R&D-based pharma.
The steps that will shape India’s AI ambition
Hosuk Lee-Makiyama, Claudia Lozano Rodríguez and Badri Narayanan Gopalakrishnan write for The Hindu about Indian IT services and consultancies held back by AI regulations run the risk of losing their hold of the global market.
UK firms cautiously optimistic on US trade deal prospects
David Henig comments in Agence France-Press the probabilities of a UK-USA trade deal.
Time and small steps needed to heal UK-EU scars
David Henig comments for Encompass on how lingering mistrust affects the improvement of EU-UK relations.
Sr. Draghi, las exportaciones no son un lastre para la competitividad de la UE
Oscar Guinea and Fredrik Erixon write a piece for Agenda Pública criticising Mario Draghi's position on EU trade openness.
UK-EU reset in the time of Trump: An Update on UK-EU Negotiations
David Henig analysis the evolving trade relations between the UK and EU for UK Trade & Business Commission.
Perspectives – Defending trade’s messy global rule-book
David Henig writes his Perspectives column about the impact of Donald Trump on global trade rules.